Bio-Techne to Present at the Bank of America Securities 2026 Global Healthcare Conference
Rhea-AI Summary
Bio-Techne (NASDAQ: TECH) said Kim Kelderman, President and CEO, will present at the Bank of America Securities 2026 Global Healthcare Conference on Tuesday, May 12, 2026 at 9:20 a.m. PDT. A live webcast will be available via the company’s investor relations IR Calendar page.
Positive
- None.
Negative
- None.
News Market Reaction – TECH
In the May 4 session, TECH declined 0.51%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Apr 16 | Brand architecture update | Positive | -1.9% | Streamlined brands into three portfolios debuting at major scientific meetings. |
| Apr 14 | Earnings call scheduled | Neutral | +2.0% | Set date and access details for Q3 fiscal 2026 results call. |
| Mar 25 | Product portfolio expansion | Positive | +0.5% | Expanded COMET spatial biology suite with new panels and amplification kits. |
| Feb 24 | Investor conferences | Positive | +5.2% | Announced presentations at two early March 2026 healthcare investor conferences. |
| Feb 16 | Regulatory milestone | Positive | -2.4% | Ella platform received CE-IVD marking enabling EU clinical deployment. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent news has produced mixed reactions, with some positive product and conference updates followed by both gains and pullbacks, indicating no consistent pattern in how shares react to announcements.
Over the last few months, Bio-Techne has reported branding, product, regulatory, and conference updates. A streamlined brand architecture on Apr 16, 2026 and spatial biology portfolio expansion on Mar 25, 2026 highlighted strategic positioning, while Ella’s CE-IVD marking on Feb 16, 2026 expanded European clinical access. Investor conference appearances and an earnings call date in February and April drew noticeable but varied price reactions. Today’s conference appearance fits this pattern of ongoing investor and scientific outreach.
AI-generated analysis. How Rhea-AI works. Not financial advice.
About Bio-Techne
Bio‑Techne Corporation (NASDAQ: TECH) is a global life sciences company headquartered in Minnesota, celebrating 50 years of empowering scientific and diagnostic communities to reach better answers. The company provides high‑quality reagents, analytical instruments, and precision diagnostics. Its portfolio is organized into three customer‑focused brands: R&D Systems™, Bio‑Techne Spatial™, and Bio‑Techne Diagnostics™, reflecting the scientific journey from discovery to translational research to clinical decision‑making. Bio‑Techne operates in 34 locations worldwide and employs approximately 3,100 people. In fiscal year 2025, the company generated over
For more information on Bio-Techne and its brands, please visit www.bio-techne.com or follow the company on social media at LinkedIn, X, or YouTube.
Contact: | David Clair, Vice President, Investor Relations |
View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-to-present-at-the-bank-of-america-securities-2026-global-healthcare-conference-302760526.html
SOURCE Bio-Techne Corporation